These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 37147088)

  • 1. Remnant Lipoprotein Cholesterol and Mortality After Acute Myocardial Infarction: Further Evidence for a Hypercholesterolemia Paradox From the TRIUMPH Registry.
    Martin SS; Faridi KF; Joshi PH; Blaha MJ; Kulkarni KR; Khokhar AA; Maddox TM; Havranek EP; Toth PP; Tang F; Spertus JA; Jones SR
    Clin Cardiol; 2015 Nov; 38(11):660-7. PubMed ID: 26459191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between alanine aminotransferase to high-density lipoprotein cholesterol ratio and nonalcoholic fatty liver disease: a retrospective cohort study in lean Chinese individuals.
    Cao C; Mo Z; Han Y; Luo J; Hu H; Yang D; He Y
    Sci Rep; 2024 Mar; 14(1):6056. PubMed ID: 38480862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein Combine Index as a Better Marker for NAFLD Identification Than Traditional Lipid Parameters.
    Qiu J; Huang X; Kuang M; Yang R; Li J; Sheng G; Zou Y
    Diabetes Metab Syndr Obes; 2024; 17():2583-2595. PubMed ID: 38946912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reply to: "Liver-adipose tissue crosstalk in nonalcoholic fatty liver disease: the emerging role of remnant cholesterol": "BAT activation might improve NAFLD in patients, but this might require developing and/or maintaining functionally relevant levels of BAT mass.".
    Lee E; Korf H; Vidal-Puig A
    J Hepatol; 2024 Mar; 80(3):e112-e114. PubMed ID: 37898347
    [No Abstract]   [Full Text] [Related]  

  • 5. Large-scale metabolomic profiling and incident non-alcoholic fatty liver disease.
    Gagnon E; Manikpurage HD; Mitchell PL; Girard A; Gobeil É; Bourgault J; Bégin F; Marette A; Thériault S; Arsenault BJ
    iScience; 2023 Jul; 26(7):107127. PubMed ID: 37456853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remnant Cholesterol Independently Predicts the Development of Nonalcoholic Fatty Liver Disease.
    Huang H; Xie J; Zeng Y; Liu Z; Miao M; Xu L; Xu C
    J Clin Endocrinol Metab; 2023 Oct; 108(11):2907-2915. PubMed ID: 37186667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Letter to the Editor From Varga: "Remnant Cholesterol Independently Predicts the Development of Nonalcoholic Fatty Liver Disease".
    Varga TV
    J Clin Endocrinol Metab; 2023 Nov; 108(12):e1757-e1758. PubMed ID: 37290047
    [No Abstract]   [Full Text] [Related]  

  • 8. Remnant cholesterol has a non-linear association with non-alcoholic fatty liver disease.
    Chen J; Su Y; Su X; Luo F
    Diabetes Res Clin Pract; 2023 Jul; 201():110733. PubMed ID: 37245725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Not only baseline but cumulative exposure of remnant cholesterol predicts the development of nonalcoholic fatty liver disease: a cohort study.
    Liu L; Wang C; Hu Z; Deng S; Yang S; Zhu X; Deng Y; Wang Y
    Environ Health Prev Med; 2024; 29():5. PubMed ID: 38325840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remnant cholesterol and severity of nonalcoholic fatty liver disease.
    Huang H; Wang J; Wu L; Ruan J; Hou L; Shen C; Xu C
    Diabetol Metab Syndr; 2023 Nov; 15(1):238. PubMed ID: 37986027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of cardiometabolic risk factors between obese and non-obese patients with nonalcoholic fatty liver disease.
    Yari Z; Fotros D; Hekmatdoost A
    Sci Rep; 2023 Sep; 13(1):14531. PubMed ID: 37666894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between remnant lipoprotein cholesterol levels and risk of non-alcoholic fatty liver disease in non-obese populations: a Chinese longitudinal prospective cohort study.
    Miao Y; Tao H
    BMJ Open; 2023 May; 13(5):e069440. PubMed ID: 37147088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between remnant lipoprotein cholesterol levels and non-alcoholic fatty liver disease in adolescents.
    Chin J; Mori TA; Adams LA; Beilin LJ; Huang RC; Olynyk JK; Ayonrinde OT
    JHEP Rep; 2020 Dec; 2(6):100150. PubMed ID: 32984791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between the ZJU index and risk of new-onset non-alcoholic fatty liver disease in non-obese participants: a Chinese longitudinal prospective cohort study.
    Zheng K; Yin Y; Guo H; Ma L; Liu R; Zhao T; Wei Y; Zhao Z; Cheng W
    Front Endocrinol (Lausanne); 2024; 15():1340644. PubMed ID: 38405152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remnant cholesterol, stronger than triglycerides, is associated with incident non-alcoholic fatty liver disease.
    Cheng Y; Zhang Q; Li H; Zhou G; Shi P; Zhang X; Guan L; Yan F; Xu C
    Front Endocrinol (Lausanne); 2023; 14():1098078. PubMed ID: 37214248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remnant Lipoprotein Cholesterol and Cardiovascular and Cerebrovascular Events in Patients with Non-Alcoholic Fatty Liver Disease.
    Pastori D; Baratta F; Novo M; Cocomello N; Violi F; Angelico F; Del Ben M
    J Clin Med; 2018 Oct; 7(11):. PubMed ID: 30360566
    [No Abstract]   [Full Text] [Related]  

  • 17. Higher serum uric acid to HDL-cholesterol ratio is associated with onset of non-alcoholic fatty liver disease in a non-obese Chinese population with normal blood lipid levels.
    Zhu W; Liang A; Shi P; Yuan S; Zhu Y; Fu J; Zheng T; Wen Z; Wu X
    BMC Gastroenterol; 2022 Apr; 22(1):196. PubMed ID: 35448944
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.